Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy

This publication has 28 references indexed in Scilit:

• Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci
  Intensive Care Medicine, 2002
• National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, Issued August 2001
  American Journal of Infection Control, 2001
• Survey of Infections Due toStaphylococcusSpecies: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999
  Clinical Infectious Diseases, 2001
• Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy
  Journal of Antimicrobial Chemotherapy, 2000
• The Development of Vancomycin Resistance in a Patient with Methicillin-ResistantStaphylococcus aureusInfection
  New England Journal of Medicine, 1999
• Emergence of Vancomycin Resistance inStaphylococcus aureus
  New England Journal of Medicine, 1999
• Staphylococcus aureus with Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal Bacteremia
  Emerging Infectious Diseases, 1999
• Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
  Journal of Antimicrobial Chemotherapy, 1997
• An overview of nosocomial infections, including the role of the microbiology laboratory
  Clinical Microbiology Reviews, 1993
• Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
  Infection Control & Hospital Epidemiology, 1992